Prevalence of Critical Congenital Heart Disease During Surgical Mission Trips to Low-Middle Income Countries. What to Expect


Published: Jun 24, 2022
Keywords:
Pediatric cardiac surgery Humanitarian Surgery Humanitarian, Critical Congenital Heart Diseases, Prevalence
Marcelo Cardarelli
https://orcid.org/0000-0002-1105-4878
Igor Polivenok
Vladimir Chadikovski
Ahmed Aboodi
Aqueel Mindel
Elena Koroson
Naema Goobha
William Novick
Abstract

Background


The incidence of congenital heart disease (CHD) is about 8 per 1000 live births. About 20% of those patients diagnosed with CHD will present early after birth with Critical Congenital Heart Disease (CCHD) necessitating a catheter or surgical intervention during the neonatal period. This is based on Western literature and Western countries. Little is known about the actual prevalence of CCHD at the time of clinical assessment and treatment during surgical missions in low and middle income countries (LMICs).


Methods


This is a retrospective study and it compares prevalence of CCHD at time of presentation for surgery in LMICs


to published data for similar cohorts in the USA. We discuss potential causes for epidemiological discrepancies


Proportions were compared using OR and 95% CI. Significance was set at p<0.01. We chose to classify our patients considering the number of ventricles (1or 2) combined with the existence of Aortic Arch obstruction (Yes/No) resulting in a CCHD classification with 4 categories


Results


Between Feb 2008 - June 2019 we operated 6115 patients in 27 countries. Of those, 243 Neonates were presented to our cardiologists


after excluding simple PDA ligations in Preterm newborns and 239 neonates were surgically treated for their CCHD


(4% of the total). overall surgical mortality among the 243 neonates operated in LMIC for their CCHD was 19.7% (n=48). Main discrepancies were in Classes 1 represented by  63% of our treated CCHD (p<.0001) while Class 4 neonates represented only 4.2% of our total (p<.0001). When compared to Western prevalence, Transposition of the Great Arteries was over-represented while some cyanotic (ToF) and non-cyanotic diagnosis (Critical Aortic Stenosis) were under-represented.


Conclusions


Patients diagnosed and treated for CCHD in LMICs during humanitarian missions represent but a very small fraction of the total number of  patients born with CCHD in those countries. 


Discrepancies in specific diagnoses and prevalence between LMIC and their high-income counterparts are likely multifactorial, and management should be adapted to the conditions of each country and health system.


Proper prenatal diagnosis, specialized critical neonatal transportation systems, countrywide availability of Prostaglandins and at least one highly functioning heart center are some of the most basic needs required in order to revert the current natural history of CCHD in countries with limited resources settings.

Article Details
  • Section
  • Articles
Downloads
Download data is not yet available.
References
Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998;4(11):1241-1243. doi:10.1038/3218
Bakker MK, Bergman JEH, Krikov S, et al. Prenatal diagnosis and prevalence of critical congenital heart defects: an international retrospective cohort study. BMJ Open 2019;9:e028139. doi:10.1136/bmjopen-2018-028139
A. H. Schultz, A. R. Localio, B. J. Clark et al. Epidemiologic Features of the Presentation of Critical Congenital Heart Disease: Implications for Screening PEDIATRICS Volume 121, Number 4, April 2008 doi:10.1542/peds.2007-0421
R. R. Clancy, S. A. McGaurn, G. Wernovsky, et al. Preoperative Risk-Of-Death Prediction Model In Heart Surgery With Deep Hypothermic Circulatory Arrest In The Neonate J Thorac Cardiovasc Surg 2000; 119:347-57
Hoffman JIE. Natural history of congenital heart disease. Problems initial assessment with special reference to ventricular septal defects. Circulation 1968; 37:97-125.
Hoffman JIE. Incidence of congenital heart disease. I. Postnatal incidence. Pediatr Cardiol 1995;16:103-13.
Hoffman J I E., Kaplan S. The Incidence of Congenital Heart Disease Journal of the American College of Cardiology Vol. 39, No. 12, 2002
D. van der Linde, E. E. M. Konings, M. A. Slager. Birth Prevalence of Congenital Heart Disease Worldwide. A systematic review and meta-analysis. J Am Coll Cardiol 2011;58:2241-7. doi:10.1016/j.jacc.2011.08.025
Zimmerman M., Sable C. Congenital heart disease in lowand-middle-income countries: Focus on sub-Saharan Africa Am J Med Genet C Semin Med Genet 2020 Mar;184(1):36- 46. doi: 10.1002/ajmg.c.31769. Epub 2020 Feb 6.
K L Brown, D A Ridout, A Hoskote, Delayed diagnosis of congenital heart disease worsens preoperative condition and outcome of surgery in neonates. Heart 2006;92:1298-1302. doi: 10.1136/hrt.2005.078097
M. E. Oster, K. A. Lee, M. A. Honein, et al. Temporal Trends in Survival Among Infants With CriticalCongenital Heart Defects Pediatrics 2013;131:e1502-e1508 doi:10.1542/peds.2012- 3435
M. N. Mat Bah, M. H. Sapian, M. T. Jamil, et al. Survival and Associated Risk Factors for Mortality Among Infants with Critical Congenital Heart Disease in a Developing Country. Pediatric Cardiology (2018) 39:1389-1396 https://doi.org/10.1007/ s00246-018-1908-6
Lytzen R, et al. “Live-born major congenital heart disease in Denmark incidence, detection rate, and termination of pregnancy rate from 1996 to 2013,” JAMA Cardiology 2018; DOI: 10.1001/jamacardio.2018.2009
Dhameer A. Mtlak and Fadhil A. Aumran 2020 IOP Conf. Ser.: Mater. Sci. Eng. 928 072130
Alaani, Tafash, Busby, et al. Uranium and other contaminants in hair from the parents of children with congenital anomalies= in Fallujah, Iraq. Conflict and Health 2011 5:15.
S. Alaani, M. A.R. Al-Fallouji, C. Busby, et al. Pilot Study of Congenital Anomaly Rates at Birth in Fallujah, Iraq, 2010. JIMA: Vol 44, 2012
Most read articles by the same author(s)